The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Read More »

A history of... GlaxoSmithKline

Assistant Editor, Hannah Blake, picks this series back up, starting here with the history of GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters ...

Read More »

GSK goes all-in on CureVac’s mRNA vaccines

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

Read More »

We Think You Can Look Beyond GSK's (LON:GSK) Lackluster Earnings

For anyone who wants to understand GSK's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by UK£3.0b due to unusual items.

Read More »

We Think You Can Look Beyond GSK's (LON:GSK) Lackluster Earnings

For anyone who wants to understand GSK's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by UK£3.0b due to unusual items. It ...

Read More »